In the global race for a coronavirus vaccine, Oxford University has leaped forward.
Human trials are already underway, and scientists hope that the vaccine will be widely available by September.
Previously, the University laboratory-developed technology to create vaccines for other diseases, including those close to COVID-19, which gave it a head start.
“I have a lot of faith in this vaccine because I’ve used this technology before,” said Sarah Gilbert, a Professor of vaccinology.
The vaccine uses genetic material from the coronavirus, which is injected into the common cold virus, previously neutralized so that it cannot spread to humans. The modified virus mimics COVID-19, mobilizing the immune system to fight the impostor, thus protecting the real coronavirus.